216 studies found for:    "Eye Diseases, Hereditary" OR "Lenz microphthalmia syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Eye Diseases, Hereditary" OR "Lenz microphthalmia syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Fundus Changes in the Microphthalmy Eyes
Condition: Eye Diseases, Hereditary
Intervention:
2 Completed Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
Conditions: Graves Ophthalmopathy;   Graves Disease;   Eye Diseases;   Thyroid Diseases;   Endocrine System Diseases;   Eye Diseases, Hereditary;   Hyperthyroidism;   Autoimmune Diseases;   Immune System Diseases
Intervention: Drug: Doxycycline
3 Recruiting Doxycycline Treatment in Mild Graves' Orbitopathy
Conditions: Graves Ophthalmopathy;   Graves Disease;   Eye Diseases;   Thyroid Diseases;   Endocrine System Diseases;   Eye Diseases, Hereditary;   Hyperthyroidism;   Autoimmune Diseases;   Immune System Diseases
Interventions: Drug: Doxycycline;   Drug: placebo
4 Active, not recruiting Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Retinal Diseases;   Eye Diseases;   Eye Disease, Hereditary;   Retinal Degeneration
Intervention: Drug: Valproic Acid
5 Completed Evaluation and Treatment of Patients With Inherited Eye Diseases
Condition: Hereditary Eye Disease
Intervention:
6 Completed Screening for Studies on Inherited Eye Diseases
Condition: Hereditary Eye Disease
Intervention:
7 Withdrawn Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Conditions: Choroidal Neovascularization;   Myopia;   Punctate Inner Choroidopathy (PIC);   Multifocal Choroiditis;   Ocular Histoplasmosis Syndrome;   Central Serous Chorioretinopathy (CSC);   Angioid Streaks;   Trauma, or Hereditary Eye Diseases
Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.);   Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
8 Recruiting Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Conditions: Muscular Dystrophy;   Congenital Muscular Dystrophy;   Fukutin-related Protein Gene;   Limb Girdle;   FKRP Gene;   Childhood Onset LGMD;   Adult Onset LGMD;   POMT1;   POMT2;   POMGnT1;   LARGE;   Alpha Dystroglycan;   Dystroglycanopathy;   Centronuclear;   Multiminicore;   Multicore;   Minicore;   Congenital Fiber Type Disproportion;   Myotubular;   Nemaline;   Congenital Myopathy;   Neuromuscular;   Rigid Spine;   Phenotype-Genotype Correlation;   Cough Assisted Device;   Neuromuscular Disease;   Respiratory Exacerbation;   Invasive Ventilation;   Chest Physiotherapy;   Congenital Myopathies;   Genetic Mutations;   Hypertrophic Cardiomyopathy;   Wheelchair Use;   Cataract;   Opthalmoplegia;   Ullrich Congenital Muscular Dystrophy;   Intermediate Collagen VI Myopathy;   Laminin Alpha 2 Related Congenital Muscular Dystrophy;   MDC1A;   Merosin Deficient Congenital Muscular Dystrophy;   Congenital Muscular Dystrophy Undiagnosed;   Congenital Muscular Dystrophy Merosin Positive;   Walker Warburg Syndrome;   Muscle Eye Brain Disease;   Fukuyama;   Integrin Alpha 7 Deficiency;   Integrin Alpha 9 Deficiency;   Laminopathy;   Lamin AC;   SEPN 1 Related Myopathies;   Bethlem Myopathy;   Dystroglycanopathies;   LGMD2K;   LGMD2I;   LGMD2L;   LGMD2N;   Actin Aggregation Myopathy;   Cap Disease;   Central Core Disease;   Centronuclear Myopathy;   Core Rod Myopathy;   Hyaline Body Myopathy;   Multiminicore Myopathy;   Myotubular Myopathy;   Nemaline Myopathy;   Tubular Aggregate Myopathy;   Zebra Body Disease Myopathy;   Congenital Myopathy Other;   Reducing Body Myopathy;   Sarcotubular Myopathy;   Spheroid Body Myopathy
Intervention:
9 Recruiting Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinitis Pigmentosa;   Retinal Degeneration
Intervention: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
10 Completed Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene
Condition: Night Blindness
Intervention: Dietary Supplement: alga Dunaliella bardawil
11 Recruiting Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.
Conditions: Retinal Disease;   Bestrophinopathy;   Best Vitelliform Macular Dystrophy;   Adult Onset Vitelliform Macular Dystrophy;   Autosomal Dominant Vitreoretinalchoroidopathy
Intervention:
12 Active, not recruiting Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: Argus 16 Retinal Stimulation System
13 Active, not recruiting Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
Condition: Graves´ Disease
Interventions: Drug: Diclofenac;   Drug: Methimazole;   Drug: L-thyroxin;   Drug: Propranolol;   Drug: Metoprolol
14 Completed Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa
Condition: Retinitis Pigmentosa
Intervention:
15 Recruiting The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Condition: Fuchs' Endothelial Dystrophy
Intervention:
16 Completed Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: transcorneal electrostimulation
17 Active, not recruiting Argus® II Retinal Stimulation System Feasibility Protocol
Condition: Retinitis Pigmentosa
Intervention: Device: Argus II Retinal Stimulation System
18 Completed Transcorneal Electrical Stimulation Therapy for Retinal Disease
Conditions: Retinitis Pigmentosa;   Macula Off;   Primary Open Angle Glaucoma;   Hereditary Macular Degeneration;   Treated Retina Detachment;   Retinal Artery Occlusion;   Retinal Vein Occlusion;   Non-Arthritic-Anterior-Ischemic Optic-Neuropathy;   Hereditary Autosomal Dominant Optic Atrophy;   Dry Age Related Macular Degeneration;   Ischemic Macula Edema
Interventions: Device: Transcorneal Electrical Stimulation;   Device: DTL-electrode attached without energy
19 Active, not recruiting Transcorneal Electrical Stimulation - Multicenter Safety Study
Condition: Retinitis Pigmentosa
Intervention: Device: Electrostimulation
20 Terminated A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Drug: Otelixizumab - low dose;   Drug: Otelixizumab - medium low dose;   Drug: Otelixizumab - medium high dose;   Drug: Otelixizumab - high dose;   Drug: Otelixizumab;   Drug: Methylprednisolone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years